← All companies

CAI

Caris Life Sciences, Inc.

CAI Nasdaq Services-Medical Laboratories EDGAR ↗

$16.32

+0.23 +1.43%

Key statistics

from XBRL data in SEC filings

Market cap

$4.61B

Revenue (TTM)

$907M

Net income (TTM)

$34.0M

EPS (TTM)

$0.35

P/E ratio

46.6

Dividend yield

—

Free cash flow

$66.9M

Cash

$820M

Total assets

$1.16B

Gross margin

—

52-week range

$14.19 – $42.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 3, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Modified rights of security holders; Amended charter or bylaws Oct 30, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Amended charter or bylaws; Other events Jun 20, 2025

Other filings

144 Aug 3, 2026 4 FORM 4 Jul 13, 2026 CERT NYSE TEXAS CERTIFICATION Jun 16, 2026 8-A12B FORM 8-A12B Jun 16, 2026 4 FORM 4 Jun 2, 2026 4 FORM 4 Jun 2, 2026 4 FORM 4 May 18, 2026 4 FORM 4 May 18, 2026 4 FORM 4 May 18, 2026 4 FORM 4 May 18, 2026 4 FORM 4 May 18, 2026 SCHEDULE 13G/A May 12, 2026 SCHEDULE 13G/A May 12, 2026 4 FORM 4 May 12, 2026 ARS Apr 23, 2026 DEFA14A Apr 23, 2026 DEF 14A Apr 23, 2026 SCHEDULE 13G/A Apr 7, 2026 4 FORM 4 Mar 10, 2026 4 FORM 4 Mar 10, 2026 4 FORM 4 Mar 10, 2026 4 FORM 4 Mar 10, 2026 4 FORM 4 Mar 10, 2026 4 FORM 4 Mar 2, 2026 4 FORM 4 Feb 27, 2026 4 FORM 4 Feb 27, 2026 4 FORM 4 Feb 27, 2026